ClinicalTrials.gov record
Active, not recruiting Not applicable Interventional

ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt System

ClinicalTrials.gov ID: NCT05686317

Public ClinicalTrials.gov record NCT05686317. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 8:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Sham-controlled Clinical Trial for Evaluation of the Edwards APTURE Transcatheter Shunt System (ALT-FLOW II)

Study identification

NCT ID
NCT05686317
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
Edwards Lifesciences
Industry
Enrollment
100 participants

Conditions and interventions

Conditions

Interventions

  • Edwards APTURE transcatheter shunt system Device
  • Sham procedure Diagnostic Test

Device · Diagnostic Test

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2023
Primary completion
Oct 31, 2026
Completion
Aug 30, 2030
Last update posted
Mar 12, 2026

2023 – 2030

United States locations

U.S. sites
18
U.S. states
11
U.S. cities
17
Facility City State ZIP Site status
University of California Irvine Irvine California 92868
University of California San Diego La Jolla California 92027
Scripps Health La Jolla California 92037
University of Southern California Los Angeles California 90033
University of California San Francisco San Francisco California 94143
Ascension Illinois Heart and Vascular Medical Group Elk Grove Illinois 60007
Kansas University Medical Center Kansas City Kansas 66160
Abbott Northwestern Hospital Minneapolis Minnesota 55407
Mayo Clinic Rochester Minnesota 55902
St. Francis Hospital & Heart Center Roslyn New York 11576
Montefiore Medical Center The Bronx New York 10467
The Christ Hospital Cincinnati Ohio 45219
The Ohio State University Columbus Ohio 43210
Oklahoma Heart Institute Tulsa Oklahoma 74104
Oregon Health and Science University Oregon City Oregon 97239
Lankenau Medical Center Wynnewood Pennsylvania 19096
Medical University of South Carolina Charleston Charleston South Carolina 29425'
HCA Houston Healthcare Medical Center Houston Texas 77004

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05686317, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 12, 2026 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05686317 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →